Developmental outcome of infants with neonatal polycythemia

V Ratrisawadi1, R Plubrukarn, K Trakulchang

  • 1Childrens' Hospital, Bangkok, Thailand.

Insights

Neonatal polycythemia is linked to poorer developmental outcomes in infants. Low birth weight and being small for gestational age are key risk factors for adverse neurodevelopment in these infants.

Area of Science:

  • Neonatal Medicine
  • Developmental Pediatrics
  • Pediatric Neurology

Background:

  • Neonatal polycythemia, a condition of high red blood cell count in newborns, can impact neurodevelopmental outcomes.
  • Previous research suggests potential links between polycythemia and developmental delays, but specific risk factors and the efficacy of interventions require further clarification.

Purpose of the Study:

  • To investigate the long-term developmental outcomes of infants diagnosed with neonatal polycythemia.
  • To identify specific risk factors associated with poor developmental outcomes in polycythemic infants.
  • To evaluate the impact of partial plasma exchange transfusion on developmental trajectories.

Main Methods:

  • A cohort study comparing 47 polycythemic infants with 21 control infants.
  • Developmental assessments were conducted at 1.5 to 2 years of age.
  • Infants were categorized into symptomatic and asymptomatic polycythemia groups; twin and non-twin sibs were considered.

Main Results:

  • Polycythemic infants showed a significantly higher incidence of abnormal developmental quotients (DQ) at 1.5-2 years (47%) compared to controls (19% including twin sibs, 5.6% excluding twin sibs).
  • No significant difference in developmental outcomes was observed between symptomatic and asymptomatic polycythemic infants.
  • Partial plasma exchange transfusion did not demonstrate a clear benefit for developmental outcomes in asymptomatic infants.

Conclusions:

  • Neonatal polycythemia is associated with an increased risk of adverse developmental outcomes.
  • Low birth weight and being small for gestational age are identified as significant risk factors for poor neurodevelopment in polycythemic infants.
  • The therapeutic benefit of partial plasma exchange transfusion on developmental outcomes in asymptomatic polycythemic infants was not evident in this study.

Related Concept Videos

Erythropoiesis01:14

Erythropoiesis

Red blood cells  (RBCs) transport oxygen to all body tissues. These cells survive only for 120 days and then need to be replenished. Erythropoiesis is the process of RBC production. In healthy individuals, erythropoiesis ensures all tissues are amply supplied with oxygen. In addition, blood loss due to injury leads to a drop in the physiological oxygen level that will cause erythropoiesis. Any defect in erythropoiesis leads to several physiological disorders, including thalassemia, anemia, and...
Disorders of Erythrocytes01:27

Disorders of Erythrocytes

Disorders of erythrocytes, or red blood cells (RBCs), include a range of conditions affecting their number, shape, or function.
Erythrocyte disorders can be broadly categorized into two main types: anemic and polycythemic conditions.
A low oxygen-carrying capacity of the blood due to the loss, lower production, or destruction of erythrocytes is termed anemia. Hemorrhagic anemia, for example, occurs when bleeding from an external wound or internal ulcer reduces erythrocyte counts.
On the other...
Development of Blood Vessels01:07

Development of Blood Vessels

The development of the vascular system in a fetus is a complex and intricate process that begins as early as 15 to 16 days post-conception. This process starts outside the embryo, specifically in the mesoderm of the yolk sac, chorion, and connecting stalk. Approximately two days later, the formation of blood vessels occurs within the embryo itself.
The initial formation of this system is facilitated by the small amount of yolk present in the ovum and yolk sac. Blood vessels originate from...
Fetal Circulation01:14

Fetal Circulation

Fetal circulation is a unique system that facilitates the exchange of gases, nutrients, and waste products between the developing fetus and the mother. This intricate process takes place through a special organ called the placenta.
Two umbilical arteries transport blood from the fetus to the placenta. At the placenta, the blood absorbs oxygen and nutrients while simultaneously eliminating waste products. This oxygen-enriched and nutrient-rich blood then returns to the fetus through one...
Factors Affecting Erythropoiesis01:24

Factors Affecting Erythropoiesis

The cardiovascular system regulates the number of erythrocytes in the bloodstream to ensure optimal oxygen transport. It also prevents over-proliferation of these cells, which helps to maintain blood viscosity and flow rate.
Several factors influence the erythrocyte production rate, with tissue oxygen level being among the most critical. Intense exercise or high altitudes can cause tissue hypoxia, which triggers the kidneys to release more erythropoietin (EPO) into the bloodstream.
EPO then...